ATP2A3
Sarcoplasmic/endoplasmic reticulum calcium ATPase 3
Also known as: AT2A3_HUMAN, SERCA3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q93084
- Gene
- ATP2A3
- Ensembl
- ENSG00000074370
- Chromosome
- 17
- Canonical length
- 999 aa
- Protein class
- Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins
OverviewNCBI Gene
This gene encodes one of the SERCA Ca(2+)-ATPases, which are intracellular pumps located in the sarcoplasmic or endoplasmic reticula of muscle cells. This enzyme catalyzes the hydrolysis of ATP coupled with the translocation of calcium from the cytosol to the sarcoplasmic reticulum lumen, and is involved in calcium sequestration associated with muscular excitation and contraction. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
999 residues, UniProt reviewed canonical sequence.
>Q93084|ATP2A3
1 MEAAHLLPAA DVLRHFSVTA EGGLSPAQVT GARERYGPNE LPSEEGKSLW ELVLEQFEDL
61 LVRILLLAAL VSFVLAWFEE GEETTTAFVE PLVIMLILVA NAIVGVWQER NAESAIEALK
121 EYEPEMGKVI RSDRKGVQRI RARDIVPGDI VEVAVGDKVP ADLRLIEIKS TTLRVDQSIL
181 TGESVSVTKH TEAIPDPRAV NQDKKNMLFS GTNITSGKAV GVAVATGLHT ELGKIRSQMA
241 AVEPERTPLQ RKLDEFGRQL SHAISVICVA VWVINIGHFA DPAHGGSWLR GAVYYFKIAV
301 ALAVAAIPEG LPAVITTCLA LGTRRMARKN AIVRSLPSVE TLGCTSVICS DKTGTLTTNQ
361 MSVCRMFVVA EADAGSCLLH EFTISGTTYT PEGEVRQGDQ PVRCGQFDGL VELATICALC
421 NDSALDYNEA KGVYEKVGEA TETALTCLVE KMNVFDTDLQ ALSRVERAGA CNTVIKQLMR
481 KEFTLEFSRD RKSMSVYCTP TRPHPTGQGS KMFVKGAPES VIERCSSVRV GSRTAPLTPT
541 SREQILAKIR DWGSGSDTLR CLALATRDAP PRKEDMELDD CSKFVQYETD LTFVGCVGML
601 DPPRPEVAAC ITRCYQAGIR VVMITGDNKG TAVAICRRLG IFGDTEDVAG KAYTGREFDD
661 LSPEQQRQAC RTARCFARVE PAHKSRIVEN LQSFNEITAM TGDGVNDAPA LKKAEIGIAM
721 GSGTAVAKSA AEMVLSDDNF ASIVAAVEEG RAIYSNMKQF IRYLISSNVG EVVCIFLTAI
781 LGLPEALIPV QLLWVNLVTD GLPATALGFN PPDLDIMEKL PRSPREALIS GWLFFRYLAI
841 GVYVGLATVA AATWWFVYDA EGPHINFYQL RNFLKCSEDN PLFAGIDCEV FESRFPTTMA
901 LSVLVTIEMC NALNSVSENQ SLLRMPPWMN PWLLVAVAMS MALHFLILLV PPLPLIFQVT
961 PLSGRQWVVV LQISLPVILL DEALKYLSRN HMHEEMSQKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ATP2A3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 10
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 175 nTPM
Expression across tissuesHPA
Tissue
- salivary gland: 175 nTPM
- lymph node: 95 nTPM
- spleen: 94 nTPM
- bone marrow: 93 nTPM
- thymus: 91 nTPM
- stomach: 88 nTPM
Single-cell type
- tuft cells: 726 nCPM
- platelets: 556 nCPM
- foveolar cells: 350 nCPM
- neutrophil progenitors: 345 nCPM
- neutrophils: 226 nCPM
- goblet cells: 197 nCPM
Immune cell
- eosinophil: 34 nTPM
- basophil: 16 nTPM
- plasmacytoid DC: 16 nTPM
- neutrophil: 13 nTPM
- naive B-cell: 11 nTPM
- gdT-cell: 11 nTPM
Brain region
- cerebellum: 42 nTPM
- choroid plexus: 32 nTPM
- midbrain: 26 nTPM
- thalamus: 24 nTPM
- basal ganglia: 17 nTPM
- amygdala: 15 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.66
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.83
- DepMap mean gene effect
- 0
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- calcium ion transmembrane transport
- calcium ion transport
- calcium ion transport from cytosol to endoplasmic reticulum
- intracellular calcium ion homeostasis
- intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress
- monoatomic ion transmembrane transport
- regulation of cardiac conduction
- transport across blood-brain barrier
Molecular functions
- ATP binding
- ATP hydrolysis activity
- calcium channel regulator activity
- calcium ion transmembrane transporter activity
- calcium-dependent ATPase activity
- cysteine-type endopeptidase activator activity involved in apoptotic process
- metal ion binding
- P-type calcium transporter activity
- transmembrane transporter binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- P-type ATPase
- Cation-transporting P-type ATPase, N-terminal
- P-type ATPase, subfamily IIA, SERCA-type
- Cation-transporting P-type ATPase, C-terminal
- P-type ATPase, A domain superfamily
- P-type ATPase, phosphorylation site
- HAD superfamily
- P-type ATPase, transmembrane domain superfamily
- P-type ATPase, cytoplasmic domain N
- HAD-like superfamily
- P-type ATPase, haloacid dehalogenase domain
- P-type ATPase, A domain
- P-type ATPase actuator domain
- Cation transporting ATPase, C-terminus
- Cation transporter/ATPase, N-terminus
- haloacid dehalogenase-like hydrolase
- P-type ATPase, cytoplasmic domain N
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ATP2A3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ATP2A3 as an antibody target. Whether an autoantibody or antibody against ATP2A3 could matter depends on whether native ATP2A3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ATP2A3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ATP2A3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...